Allergan plc (NYSE:AGN)

172.49
Delayed Data
As of Jun 21
 -2.70 / -1.54%
Today’s Change
142.81
Today|||52-Week Range
256.80
+5.45%
Year-to-Date

Today’s Trading

Previous close175.19
Today’s open174.34
Day’s range171.89 - 175.49
Volume1,248,173
Average volume (3 months)3,071,908
Market cap$52.3B
Data as of 4:02pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-134.55%
Earnings growth (this year)-2.09%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+9.40%
P/E ratioNM
Price/Sales3.43
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.98-2.71%
LLYEli Lilly and Co-0.21-0.24%
ABTAbbott Laboratories-0.39-0.63%
NVONovo Nordisk+0.75+1.64%
Data as of 4:02pm ET, 06/21/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$4.08
Annual revenue (last year)$15.9B
Annual profit (last year)-$4.1B
Net profit margin-23.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Executive Vice President-
Global Operations
Wayne R. Swanton
Corporate headquarters
Dublin, Dublin

Forecasts